Login / Signup
Editorial: Is vedolizumab the preferred biologic therapy for biologic-naïve patients with ulcerative colitis?
Takayuki Yamamoto
Published in:
Alimentary pharmacology & therapeutics (2023)
Keyphrases
</>
ulcerative colitis
rheumatoid arthritis
patients with inflammatory bowel disease